| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/26/2023 | 14.81% | Cantor Fitzgerald | → $29 | Initiates Coverage On | → Overweight |
| 01/05/2023 | -4.99% | Piper Sandler | $26 → $24 | Maintains | Neutral |
| 01/04/2023 | 26.68% | B of A Securities | $28 → $32 | Upgrades | Neutral → Buy |
| 11/03/2022 | 10.85% | JP Morgan | $29 → $28 | Maintains | Overweight |
| 11/03/2022 | 10.85% | Needham | $30 → $28 | Maintains | Buy |
| 10/20/2022 | 2.93% | Morgan Stanley | $28 → $26 | Maintains | Equal-Weight |
| 09/30/2022 | 18.76% | Truist Securities | → $30 | Initiates Coverage On | → Buy |
| 08/04/2022 | 10.85% | Morgan Stanley | $26 → $28 | Maintains | Equal-Weight |
| 08/04/2022 | 18.76% | Needham | $23 → $30 | Maintains | Buy |
| 07/07/2022 | 18.76% | Canaccord Genuity | → $30 | Initiates Coverage On | → Buy |
| 05/11/2022 | 2.93% | Morgan Stanley | $40 → $26 | Maintains | Equal-Weight |
| 05/10/2022 | -8.95% | Needham | $32 → $23 | Maintains | Buy |
| 03/21/2022 | 42.52% | Stifel | $45 → $36 | Maintains | Buy |
| 02/14/2022 | 58.35% | Morgan Stanley | $43 → $40 | Maintains | Equal-Weight |
| 02/09/2022 | 26.68% | Needham | $71 → $32 | Maintains | Buy |
| 12/09/2021 | 78.15% | Stifel | → $45 | Upgrades | Hold → Buy |
| 11/08/2021 | 181.08% | Needham | $66 → $71 | Maintains | Buy |
| 08/20/2021 | 58.35% | Morgan Stanley | $63 → $40 | Maintains | Equal-Weight |
| 08/06/2021 | 117.74% | Oppenheimer | $61 → $55 | Maintains | Outperform |
| 08/06/2021 | 161.28% | Needham | $86 → $66 | Maintains | Buy |
| 07/27/2021 | 149.41% | Morgan Stanley | $69 → $63 | Maintains | Equal-Weight |
| 05/07/2021 | 173.16% | Morgan Stanley | $76 → $69 | Maintains | Equal-Weight |
| 05/07/2021 | 240.46% | Needham | $95 → $86 | Maintains | Buy |
| 04/23/2021 | 196.91% | Berenberg | → $75 | Initiates Coverage On | → Buy |
| 02/12/2021 | 200.87% | Morgan Stanley | $70 → $76 | Maintains | Equal-Weight |
| 02/12/2021 | 276.09% | Needham | $91 → $95 | Maintains | Buy |
| 02/12/2021 | 224.62% | Keybanc | $80 → $82 | Maintains | Overweight |
| 01/19/2021 | 216.71% | Keybanc | $86 → $80 | Maintains | Overweight |
| 11/05/2020 | 260.25% | Needham | $89 → $91 | Maintains | Buy |
| 10/12/2020 | 256.29% | Oppenheimer | → $90 | Initiates Coverage On | → Outperform |
| 10/12/2020 | 165.24% | Morgan Stanley | → $67 | Initiates Coverage On | → Equal-Weight |
| 10/12/2020 | 196.91% | Stifel | → $75 | Initiates Coverage On | → Hold |
| 10/12/2020 | — | William Blair | Initiates Coverage On | → Market Perform | |
| 10/12/2020 | 240.46% | Keybanc | → $86 | Initiates Coverage On | → Overweight |
What is the target price for JFrog (FROG)?
The latest price target for JFrog (NASDAQ: FROG) was reported by Cantor Fitzgerald on January 26, 2023. The analyst firm set a price target for $29.00 expecting FROG to rise to within 12 months (a possible 14.81% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for JFrog (FROG)?
The latest analyst rating for JFrog (NASDAQ: FROG) was provided by Cantor Fitzgerald, and JFrog initiated their overweight rating.
When is the next analyst rating going to be posted or updated for JFrog (FROG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of JFrog, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for JFrog was filed on January 26, 2023 so you should expect the next rating to be made available sometime around January 26, 2024.
Is the Analyst Rating JFrog (FROG) correct?
While ratings are subjective and will change, the latest JFrog (FROG) rating was a initiated with a price target of $0.00 to $29.00. The current price JFrog (FROG) is trading at is $25.26, which is within the analyst's predicted range.